SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5,980.54 |
Enterprise Value ($M) | 14,187.54 |
Book Value ($M) | -1,066.00 |
Book Value / Share | -4.19 |
Price / Book | -5.61 |
NCAV ($M) | -7,916.00 |
NCAV / Share | -31.12 |
Price / NCAV | -0.76 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.11 |
Return on Assets (ROA) | 0.09 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.17 |
Current Ratio | 1.56 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3,931.00 |
Assets | 10,955.00 |
Liabilities | 11,847.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6,174.00 |
Operating Income | 1,912.00 |
Net Income | 917.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 858.00 |
Cash from Investing | -420.00 |
Cash from Financing | -433.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Mawer Investment Management Ltd. | 5.39 | ||
13G | State Street Corp | 5.06 | ||
13G/A | Vanguard Group Inc | 12.37 | 9.37 | |
13G/A | BlackRock Inc. | 6.40 | -3.03 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
218,047 | 1,761,206 | 12.38 | |
284,558 | 1,582,720 | 17.98 | |
219,230 | 1,422,322 | 15.41 | |
128,430 | 1,034,324 | 12.42 | |
206,821 | 1,124,323 | 18.40 | |
(click for more detail) |
Similar Companies | |
---|---|
NUVB – Nuvation Bio Inc | NVO – Novo-Nordisk A/S |
NVS – Novartis AG | PBH – Prestige Brands Holdings, Inc. |
PFE – Pfizer Inc. |
Financial data and stock pages provided by
Fintel.io